Chagas Disease Treatment Market Size Was Valued at USD 9.28 Million in 2023, and is Projected to Reach USD 17.50 Million by 2032, Growing at a CAGR of 7.3% From 2024-2032.
Chagas disease resulting from the Trypanosoma cruzi insect-borne parasite affects mainly Latin America but is also endemic in some other countries. Management of Chagas disease primarily targets doing away with the acute phase and to contain the chronic phase with medications, which help decrease the parasite load of the disease and prevent further development of cardiac and gastrointestinal complications of Chagas disease in chronic phase.